8 Quotes by Nancy Havens

I can't imagine why anyone would want to buy Qwest.

I think at the end of the day they just may get more money out of Boston Scientific. They've been very clear with Boston Scientific about what they have to do to complete that transaction.

Right now, with the value of (Boston Scientific) stock where it is, the deal is worth $79 (per share). I don't think J&J is going to come back and I certainly don't think they're going to come back with anything more than $76 per share. Most people think J&J is done with (Guidant) and gone.

I think they probably thought they were giving (Guidant) the board more time (to weight the offer). When they realized they were giving J&J more time, they weren't so excited about that.

Johnson & Johnson is negotiating in public, and that's never a good sign. We don't expect them to get the deal done immediately, but there are plenty of opportunities for the deal to come together over the coming months.

The regulatory risks of this are surely political. It's an oil and gas deal, and when the price of oil and gas are very high. They will certainly force an FTC investigation.

There's a certain poetic license to $76, given that was the original J&J bid.

This is a knock-your-socks-off offer. I don't see how they could not deem it superior.